P
CRBU icon

&Partners’s Caribou Biosciences CRBU Stock Holding History

&Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2K Hold
32,505
– – ﹤0.01% 2488
2026
Q1 		$61.8K Sell
32,505
-3,000
-8% -$5.15K ﹤0.01% 2362
2025
Q4 		$56.5K Sell
35,505
-8,634
-20% -$18.1K ﹤0.01% 2239
2025
Q3 		$103K Sell
44,139
-292,426
-87% -$552K ﹤0.01% 2051
2025
Q2 		$424K Buy
+336,565
New +$331K ﹤0.01% 1431

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

&Partners's CRBU Position: Q2 2026 in Review

&Partners held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 32,505 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

&Partners first reported a position in CRBU in Q2 2025 and has held it in 5 quarters since. The position peaked at $424K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • &Partners held 32,505 shares of Caribou Biosciences worth $57.2K as of Q2 2026.
  • &Partners left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2488 holding.
  • &Partners first reported a position in Caribou Biosciences in Q2 2025 and has held it in 5 quarters since.
  • &Partners's Caribou Biosciences position peaked at $424K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.